A Trial of GFH018 and Toripalimab in Combination With Concurrent Chemoradiotherapy in Stage III NSCLC Chemoradiotherapy in Stage III NSCLC

NCT05386888 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

INDUSTRY

Sponsor class

Conditions

NSCLC, Stage III

Interventions

DRUG: GFH018
DRUG: Toripalimab
DRUG: Paclitaxel
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Pemetrexed
RADIATION: Thoracic Radiation Therapy (TRT)
DRUG: GFH018

Sponsor

Genfleet Therapeutics (Shanghai) Inc.